These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 29271576)
1. Effects of Omega-3 Fatty Acids on Markers of Inflammation in Patients With Chronic Kidney Disease: A Controversial Issue. Hu C; Yang M; Zhu X; Gao P; Yang S; Han Y; Chen X; Xiao L; Yuan S; Liu F; Kanwar YS; Sun L Ther Apher Dial; 2018 Apr; 22(2):124-132. PubMed ID: 29271576 [TBL] [Abstract][Full Text] [Related]
2. Oral supplementation with omega-3 fatty acids and inflammation markers in patients with chronic kidney disease in hemodialysis. Valle Flores JA; Fariño Cortéz JE; Mayner Tresol GA; Perozo Romero J; Blasco Carlos M; Nestares T Appl Physiol Nutr Metab; 2020 Aug; 45(8):805-811. PubMed ID: 31935118 [TBL] [Abstract][Full Text] [Related]
3. Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials. Saglimbene VM; Wong G; van Zwieten A; Palmer SC; Ruospo M; Natale P; Campbell K; Teixeira-Pinto A; Craig JC; Strippoli GFM Clin Nutr; 2020 Feb; 39(2):358-368. PubMed ID: 30905498 [TBL] [Abstract][Full Text] [Related]
4. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial. de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111 [TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer. Mocellin MC; Camargo CQ; Nunes EA; Fiates GMR; Trindade EBSM Clin Nutr; 2016 Apr; 35(2):359-369. PubMed ID: 25982417 [TBL] [Abstract][Full Text] [Related]
6. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients. Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Abdollahi A; Hashemi-Nazari SS; Mansournia MA J Ren Nutr; 2014 May; 24(3):177-85. PubMed ID: 24613294 [TBL] [Abstract][Full Text] [Related]
8. Beneficial Effects of 6-Month Supplementation with Omega-3 Acids on Selected Inflammatory Markers in Patients with Chronic Kidney Disease Stages 1-3. Pluta A; Stróżecki P; Kęsy J; Lis K; Sulikowska B; Odrowąż-Sypniewska G; Manitius J Biomed Res Int; 2017; 2017():1680985. PubMed ID: 29349065 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients. Malekshahi Moghadam A; Saedisomeolia A; Djalali M; Djazayery A; Pooya S; Sojoudi F Singapore Med J; 2012 Sep; 53(9):615-9. PubMed ID: 23023905 [TBL] [Abstract][Full Text] [Related]
10. The effects of omega-3 fatty acid supplementation on inflammatory factors in HIV-infected patients: A systematic review and meta-analysis of randomized clinical trials. Morvaridzadeh M; Sepidarkish M; Yavari M; Tahvilian N; Heydarian A; Khazdouz M; Farsi F; Persad E; Heshmati J Cytokine; 2020 Dec; 136():155298. PubMed ID: 32977239 [TBL] [Abstract][Full Text] [Related]
11. Effect of omega-3 fatty acids supplementation on cardio-metabolic and oxidative stress parameters in patients with chronic kidney disease: a systematic review and meta-analysis. Fazelian S; Moradi F; Agah S; Hoseini A; Heydari H; Morvaridzadeh M; Omidi A; Pizarro AB; Ghafouri A; Heshmati J BMC Nephrol; 2021 May; 22(1):160. PubMed ID: 33933009 [TBL] [Abstract][Full Text] [Related]
12. The Effects of OMEGA-3 Fatty Acid Supplementation Upon Interleukin-12 and Interleukin-18 in Chronic Kidney Disease Patients. Yong K; Mori T; Chew G; Beilin LJ; Puddey I; Watts GF; Irish A; Dogra G; Boudville N; Lim W J Ren Nutr; 2019 Sep; 29(5):377-385. PubMed ID: 30803749 [TBL] [Abstract][Full Text] [Related]
14. The Effects of Omega-3 Fatty Acids Supplementation on Inflammatory Factors in Cancer Patients: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials. Amiri Khosroshahi R; Heidari Seyedmahalle M; Zeraattalab-Motlagh S; Fakhr L; Wilkins S; Mohammadi H Nutr Cancer; 2024; 76(1):1-16. PubMed ID: 37897076 [TBL] [Abstract][Full Text] [Related]
15. Omega-3 supplementation effects on cardiovascular risk and inflammatory profile in chronic kidney disease patients in hemodialysis treatment: An intervention study. de Lima K; Mazur CE; Vicente Cavagnari MA; Castilho AJ; Schiessel DL Clin Nutr ESPEN; 2023 Dec; 58():144-151. PubMed ID: 38056999 [TBL] [Abstract][Full Text] [Related]
16. Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients. Asemi Z; Soleimani A; Shakeri H; Mazroii N; Esmaillzadeh A Int Urol Nephrol; 2016 Nov; 48(11):1887-1895. PubMed ID: 27554670 [TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of n-3 polyunsaturated fatty acids effects on circulating acute-phase protein and cytokines in gastric cancer. Mocellin MC; Fernandes R; Chagas TR; Trindade EBSM Clin Nutr; 2018 Jun; 37(3):840-850. PubMed ID: 28666598 [TBL] [Abstract][Full Text] [Related]
18. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H J Am Nutr Assoc; 2022; 41(7):697-712. PubMed ID: 34635026 [No Abstract] [Full Text] [Related]
19. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670 [TBL] [Abstract][Full Text] [Related]
20. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]